![](https://investorshub.advfn.com/uicon/604300.png?cb=1489719026)
Friday, August 20, 2021 4:12:06 PM
3 Reasons $RGBP Could Be Sold For CASH$$
1) The Company is Down, But Not Out.
2) The Science is MRNA Blockbuster But Bank Account isn’t.
3) Dr Koos is near the End of a long Career.
Thanks to OTCShotcaller Here's Reason #4
#4- It's going to take hundreds of millions of dollars to put the re-activated Patents into FDA Approved Clinical Trials.
Here's a link that provides an estimate for this.
https://www.jhsph.edu/news/news-releases/2018/cost-of-clinical-trials-for-new-drug-FDA-approval-are-fraction-of-total-tab.html
The average or "median" cost in 2015-2016 was $16 Million per clinical trial. Today it would be much higher.
Also, this article points out that for clinical trials that involve examining "a drug's ability to prevent a clinically meaningful outcome..", the median cost is much higher, i.e. $65 Million per trial, and again that was back in 2015-2016.
So yes as I said, to put those re-activated Patents into clinical trials is going to cost a absolute FORTUNE....ALL CASH!!
Big Pharma Buy Out is the only thing that makes sense, IMO.
Opinion Only..
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM